Target Name: LOC105378526
NCBI ID: G105378526
Review Report on LOC105378526 Target / Biomarker Content of Review Report on LOC105378526 Target / Biomarker
LOC105378526
Other Name(s): Uncharacterized LOC105378526

LOC105378526: A Potential Drug Target for Cancer and Neurodegenerative Diseases

LOC105378526 is a protein that is found in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the LOC105378 family of proteins, which are known for their role in cell signaling and inflammation.

Recent studies have identified LOC105378526 as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because the protein is involved in a number of cellular processes that are disrupted in these conditions, including inflammation, cell proliferation, and survival.

One of the key reasons for the potential of LOC105378526 as a drug target is its role in the regulation of inflammation. In response to injury or damage, the body mounts an inflammatory response to protect the body from infection and tissue repair. However, chronic inflammation can lead to a host of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

LOC105378526 has been shown to play a key role in the regulation of this inflammatory response. Studies have shown that LOC105378526 is involved in the production of pro-inflammatory cytokines, which are important drivers of inflammation. Additionally, LOC105378526 has been shown to inhibit the activity of a protein called nuclear factor kappa B (NF-kappa-B), which is a key regulator of inflammation.

This is potentially interesting becauseNF-kappa-B is a protein that is involved in the regulation of many cellular processes, including cell signaling, DNA replication, and cell survival. Therefore, inhibiting its activity could have a wide range of effects on cellular processes throughout the body.

Another potential mechanism by which LOC105378526 could be a drug target is its role in cell proliferation. The regulation of cell proliferation is a critical aspect of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

LOC105378526 has been shown to play a key role in the regulation of cell proliferation. Studies have shown that LOC105378526 is involved in the production of cell cycle proteins, which are important for the division of cells. Additionally, LOC105378526 has been shown to inhibit the activity of a protein called cyclin D1, which is involved in the regulation of cell cycle progression.

This is potentially interesting because cell proliferation is a critical aspect of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, inhibiting cell proliferation could have a wide range of effects on the development and progression of these conditions.

In conclusion, LOC105378526 is a protein that is involved in a number of cellular processes throughout the body, including inflammation, cell proliferation, and cell survival. As a result, it is a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of LOC105378526 as a drug target and to develop effective treatments.

Protein Name: Uncharacterized LOC105378526

The "LOC105378526 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378526 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962